Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
B-cell receptor-associated protein 31 (BAP31, also known as BCAP31) is a ubiquitously expressed, multi-pass transmembrane protein predominantly located in the membrane of the endoplasmic reticulum (ER)[1][2][3]. Functioning both as a broad-specificity membrane protein chaperone and a quality control factor, BAP31 plays crucial roles in exporting properly folded membrane proteins from the ER to the Golgi, identifying abnormally folded proteins for ER-associated degradation, and acting as a tether and regulatory hub at mitochondria-associated membranes (MAMs)[1][2][3]. It regulates various cellular processes including autophagy, apoptosis (mediating both anti-apoptotic and pro-apoptotic functions depending on its cleavage state), ER and mitochondrial homeostasis, and immune response[1][2][3]. Loss-of-function mutations in BAP31 are linked to severe X-linked neurological disorders such as deafness, dystonia, and central hypomyelination syndrome (DDCH) as well as broader roles in cancer, metabolic disease, and viral pathogenesis[1][2][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on B-cell receptor-associated protein 31 (BAP31).